Test Code INSLN INSULIN, SERUM
Additional Codes
Software | Test Code |
---|---|
Label Text | INSLN |
EPIC | LAB527 |
Performing Laboratory
NorDx Laboratories
Useful For
Determination of insulin levels, along with proinsulin and C-peptide measurements, may be useful in the diagnosis of insulinoma.
The assay may also be used in the management of diabetes mellitus.
Method Name
Electrochemiluminescent Immunoassay (ECLIA)
Reference Values
2.6-24.9 uU/mL
Reference ranges are for adult and fasting specimens only.
Days and Times Test Performed
Monday through Sunday
Report Available
1 Day
Available Stat
Specimen Type
Serum
Preferred Container
Serum Separator Tube (SST)
Preferred Volume
Serum: 1 mL (Serum Separator Tube (SST))
Minimum Volume
Serum: 0.25 mL (Serum Separator Tube (SST))
Specimen Collection and Handling
1. Spin specimen, separate from clot and send frozen.
2. If multiple specimens are collected, send separate request form for each specimen. Clearly label each specimen with the collection time.
3. Sample should not be collected on patients receiving therapy with high biotin doses (i.e. >5 mg/day) until at least 8 hours after the last biotin administration.
Specimen Stability Information
Specimen Type: Serum
Frozen: 3 Months
Refrigerated: 2 Days
Must be spun/separated within: 2 Hours
Add On Capable
Yes
Advance Beneficiary Notice Requirements
No ABN Required
CPT Code Information
CPT Code |
CPT Description |
CPT Disclaimer |
---|---|---|
83525 | Insulin, Total, Quantitative |
Keywords
INSULIN
ISLET CELL TUMOR
Performing Laboratory Location
NorDx Laboratories
Clinical Significance
This test is intended for adult patients only.
Patients with a history of insulin usage may have insulin antibodies which cause an inaccurate assay result.
This procedure is specific for human insulin, therefore some synthetic insulins may not be measured accurately.
Erroneous findings may be obtained from samples taken from patients who have been treated with monoclonal mouse antibodies or have received them for diagnostic purposes.
Extremely high titers of antibodies to streptavidin can occur in isolated cases and cause interference.
No sample should be collected on patients receiving therapy with high biotin doses(i.e. biotin therapy for Multiple Sclerosis or oncology patients; skin, hair and nail supplements, or multivitamins containing > 5 mg/day) until at least 12 hours after the last biotin administration. If unsure, or if the clinical picture does not fit the results please contact the laboratory . We have methods to check for biotin interference as well as for any other interferences and for the accuracy of the results.
Biotin interference would falsely decrease the result of this assay.
LOINC Code Information
20448-7
Acceptable Alternative Container(s)
Plasma Separator Tube (PST)
Red Top Tube
Rejection Information
Hemolysis interferes with this assay.